MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0104746
Biosafe Pharmaceuticals Private Limited - pharma in Ambarnath, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.51 Cr
▲ 39.86% YoY
Net profit · FY 2025
₹1.15 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹4.18 Lakh
EBITDA margin 2.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
About Biosafe Pharmaceuticals Private Limited
Data last updated:
Biosafe Pharmaceuticals Private Limited is a private limited company based in Ambarnath, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52311MH2010PTC202132. Its GSTIN is 27AAECB4456A1Z1 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Santosh Kumar Singh and Vivek Kumar Surendra Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No.240 2nd Floor, Globe Business Park Kalyan – Badlapur Road Ambarnath Thane, Maharashtra, India – 421505.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.51 Cr. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 0.8%) and EBITDA of ₹4.18 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
Biosafe Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0104746). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biosafepharma.in.
Company details
CIN U52311MH2010PTC202132
Registration Number 202132
Incorporation Date 17 April 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0104746
Key People
Santosh Kumar Singh Director Vivek Kumar Surendra Sharma Director Sunil Kumar Harishankar Mishra Director Recognitions & Rankings of Biosafe Pharmaceuticals
Contact details
Biosafe Pharmaceuticals Private Limited's registered office is in Ambarnath, Maharashtra. Its website is biosafepharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No.240 2nd Floor, Globe Business Park Kalyan – Badlapur Road Ambarnath Thane, Maharashtra, India – 421505
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Biosafe Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Biosafe Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biosafe Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Biosafe Pharmaceuticals Private Limited, buy the company report.
Financials of Biosafe Pharmaceuticals Private Limited
FY 2025 filings availableBiosafe Pharmaceuticals Private Limited reported revenue of ₹1.51 Cr for FY 2025.
Revenue · FY 2025
₹1.51 Cr
Net profit · FY 2025
₹1.15 Lakh margin 0.8%
EBITDA · FY 2025
₹4.18 Lakh margin 2.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 12%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 40%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biosafe Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biosafe Pharmaceuticals Private Limited
Biosafe Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Singh | Director | 03 Jan 2014 | 12 Years 9 Months | Current |
| Vivek Kumar Surendra Sharma | Director | 17 Apr 2010 | 16 Years 6 Months | Current |
| Sunil Kumar Harishankar Mishra | Director | 17 Apr 2010 | 16 Years 6 Months | Current |
Shareholding
The shareholding of Biosafe Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Biosafe Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2023 | 100790584 | Others | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Biosafe Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biosafe Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biosafe Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECB4456A1Z1 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biosafe Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biosafe Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Santosh Kumar Singh was appointed as Director on 03 Jan 2014.
AGM
Biosafe Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biosafe Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100790584 was registered on 30 Sep 2023.
Appointed
Santosh Kumar Singh was appointed as Director.
Ceased
Rajesh Girijashankar Tiwari ceased to be Director.
Appointed
Sunil Kumar Harishankar Mishra was appointed as Director.
Appointed
Vivek Kumar Surendra Sharma was appointed as Director.
Incorporation
17 Apr 2010
Biosafe Pharmaceuticals Private Limited was registered on 17 Apr 2010 with Roc Mumbai Ii & aged 16 years 6 months as per MCA records.
Frequently asked questions
Biosafe Pharmaceuticals is an active private limited company based in Ambarnath, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 April 2010 (16+ years old) and is registered under CIN U52311MH2010PTC202132.
Biosafe Pharmaceuticals has 3 current directors:
- Santosh Kumar Singh - Director
- Vivek Kumar Surendra Sharma - Director
- Sunil Kumar Harishankar Mishra - Director
The latest financial statements of Biosafe Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biosafe Pharmaceuticals is 27AAECB4456A1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Biosafe Pharmaceuticals is U52311MH2010PTC202132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biosafe Pharmaceuticals was incorporated on 17 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Santosh Kumar Singh was appointed as Director on 03 Jan 2014. Rajesh Girijashankar Tiwari ceased to be Director on 06 Aug 2013. Sunil Kumar Harishankar Mishra was appointed as Director on 17 Apr 2010. Biosafe Pharmaceuticals has 4 board changes on record in total.
Yes, Biosafe Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0104746).
Biosafe Pharmaceuticals can be reached through the website biosafepharma.in. Its registered office is in Ambarnath, Maharashtra, India.
The registered office of Biosafe Pharmaceuticals is at Unit No.240 2nd Floor, Globe Business Park Kalyan – Badlapur Road Ambarnath Thane, Maharashtra, India – 421505.